Technology News and Research

RSS

Crucell and AIDS Vaccine Initiative have signed an exclusive license agreement to develop an AIDS vaccine

Dutch biotechnology company Crucell and the International AIDS Vaccine Initiative (IAVI) have signed an exclusive license agreement to develop an AIDS vaccine based on Crucell’s AdVac® technology.

20 Sep 2004

Project to find out how European governments could fight obesity

In response to the alarming rise in obesity across the developed world, a University of Sussex food policy researcher is leading a project to find out how European governments could fight the flab.

20 Sep 2004

Oral appliances effective in treating obstructive sleep apnea

Obstructive sleep apnea syndrome (OSAS) is a disorder characterized by repeated episodes of reductions or cessation in breathing during sleep. Millions of Americans, both men and women, have this medical problem

18 Sep 2004

Study hints at antioxidants being able to prevent and restore hearing loss

In a preliminary study, researchers find that vitamin E may be effective in restoring sudden onset hearing loss of unknown origin (idiopathic sudden hearing loss). These findings suggest that further research may reveal the role of antioxidants in the prevention and restoration of hearing loss.

18 Sep 2004

Reading performance is not affected once otitis media has been cured

One year ago, study results were presented addressing the reading performance in children with otitis media in early childhood. The findings revealed that middle ear diseases during early years and the attendant hearing losses adversely affect reading performance in first and second graders.

18 Sep 2004

MRI is becoming more recognized as useful in the etiological investigation of sudden deafness

For the patient, sudden deafness can be terrifying. For the specialist, this disorder can be most challenging for the cause of sudden deafness cannot be readily determined by use of the most advanced diagnostic tests.

17 Sep 2004

Study compares coblation tonsillectomy to traditional method of removing tonsils

Tonsillectomy remains one of the most common childhood surgeries with an increasing number of the surgeries being done to treat obstructive sleep apnea or sleep disordered breathing.

17 Sep 2004

New high-tech pacifier helps babies who are born prematurely

The pacifier also may reduce the incidence or severity of certain developmental disabilities that appear in early childhood and beyond as well as possibly boost IQ.

16 Sep 2004

Research findings could lead to more effective repellents

If you think it doesn't do much good to swipe the fly that's going after the potato salad, guess again. You may be discouraging the fly's colleagues from taking up the raid.

15 Sep 2004

HHS enhances Medicare drug card program to help seniors

Health and Human Services Secretary Tommy G. Thompson today announced new measures to help seniors get the lowest price possible for their medicines by allowing them -- for the first time -- to compare prices for similar drugs used to treat common diseases such as high cholesterol or blood pressure.

15 Sep 2004

Cars that tell people where to go

A three-year Macquarie University research project has studied the differences in how humans and computers talk - by analysing how each give driving directions.

14 Sep 2004

BNCT treatment has had an excellent response in a patient with head and neck cancer

A Finnish research group has been the first in the world to publish an article in which BNCT treatment has had an excellent response in a patient with head and neck cancer for whom there was no other treatment available.

14 Sep 2004

Liver cancer genes cluster into two subsets that correlate to survival

An analysis of the gene expression patterns of 91 unrelated liver tumors revealed two distinctive subclasses highly associated with patient survival, according to a new study published in the September 2004 issue of Hepatology.

14 Sep 2004

ID Biomedical to supply meningitis C vaccine to the Canadian government

The Canadian government has retained an option to purchase additional product from the Company in the third and final year of the contract. The total value of the contract, including the third year option, could total approximately $30 million to ID Biomedical.

14 Sep 2004

Crocodile blood could help make artificial blood

Pioneering research being undertaken on crocodile blood to see if it can help in making artificial blood is revealed tomorrow in an innovative new, free, emailed, quarterly science magazine called Velocity.

14 Sep 2004

Micro-thin implantable films may one day allow patients to forgo daily injections and pills

Researchers at the Georgia Institute of Technology have developed a material that may one day allow patients to forgo daily injections and pills and receive prescriptions instead through micro-thin implantable films that release medication according to changes in temperature.

14 Sep 2004

Researchers find way to clean up the drugs market

Researchers from the University of Cambridge and the Massachusetts Institute of Technology have made a breakthrough by using supercritical carbon dioxide (scCO2) as a reaction medium for the preparation of molecules of interest to the pharmaceutical industry.

13 Sep 2004

Potential new drug for the treatment of sickle cell disease

The results were published in the June 2004 issue of The British Journal of Haematology (BJH). MX-1520 is a prodrug of vanillin, a very popular food additive generally regarded as safe (GRAS) by the FDA.

13 Sep 2004

Measuring body fat has just got easier and a whole lot more sophisticated

The space capsule-like pod measures and tracks body fat and lean muscle mass using air displacement technology – replacing the tape measure and callipers or water displacement tanks previously used in research.

13 Sep 2004

Chiron announces settlement with Roche in HIV patent dispute

Chiron Corporation has announced that it has reached a settlement with F. Hoffmann-La Roche (Roche) in a dispute over licensing fees and royalties that Chiron had asserted was owed to the company under a licensing agreement related to its U.S. Patent No. 6,531,276 (the "276 Patent").

12 Sep 2004